236 related articles for article (PubMed ID: 11778664)
1. Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water.
Guha Mazumder DN; De BK; Santra A; Ghosh N; Das S; Lahiri S; Das T
J Toxicol Clin Toxicol; 2001; 39(7):665-74. PubMed ID: 11778664
[TBL] [Abstract][Full Text] [Related]
2. Randomized placebo-controlled trial of 2,3-dimercaptosuccinic acid in therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water.
Guha Mazumder DN; Ghoshal UC; Saha J; Santra A; De BK; Chatterjee A; Dutta S; Angle CR; Centeno JA
J Toxicol Clin Toxicol; 1998; 36(7):683-90. PubMed ID: 9865236
[TBL] [Abstract][Full Text] [Related]
3. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal.
Guha Mazumder DN
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Jan; 38(1):141-63. PubMed ID: 12635824
[TBL] [Abstract][Full Text] [Related]
4. Arsenic Toxicity: Molecular Targets and Therapeutic Agents.
Nurchi VM; Djordjevic AB; Crisponi G; Alexander J; Bjørklund G; Aaseth J
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033229
[No Abstract] [Full Text] [Related]
5. Chronic arsenic toxicity in Bangladesh and West Bengal, India--a review and commentary.
Rahman MM; Chowdhury UK; Mukherjee SC; Mondal BK; Paul K; Lodh D; Biswas BK; Chanda CR; Basu GK; Saha KC; Roy S; Das R; Palit SK; Quamruzzaman Q; Chakraborti D
J Toxicol Clin Toxicol; 2001; 39(7):683-700. PubMed ID: 11778666
[TBL] [Abstract][Full Text] [Related]
6. Arsenic and non-malignant lung disease.
Guha Mazumder DN
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1859-67. PubMed ID: 17952787
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of spirulina extract plus zinc in patients of chronic arsenic poisoning: a randomized placebo-controlled study.
Misbahuddin M; Islam AZ; Khandker S; Ifthaker-Al-Mahmud ; Islam N; Anjumanara
Clin Toxicol (Phila); 2006; 44(2):135-41. PubMed ID: 16615668
[TBL] [Abstract][Full Text] [Related]
8. Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid.
Wax PM; Thornton CA
J Toxicol Clin Toxicol; 2000; 38(7):777-80. PubMed ID: 11192465
[TBL] [Abstract][Full Text] [Related]
9. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
Aposhian HV; Zheng B; Aposhian MM; Le XC; Cebrian ME; Cullen W; Zakharyan RA; Ma M; Dart RC; Cheng Z; Andrewes P; Yip L; O'Malley GF; Maiorino RM; Van Voorhies W; Healy SM; Titcomb A
Toxicol Appl Pharmacol; 2000 May; 165(1):74-83. PubMed ID: 10814555
[TBL] [Abstract][Full Text] [Related]
10. Strategies for safe and effective therapeutic measures for chronic arsenic and lead poisoning.
Kalia K; Flora SJ
J Occup Health; 2005 Jan; 47(1):1-21. PubMed ID: 15703449
[TBL] [Abstract][Full Text] [Related]
11. Arsenic intoxication: general aspects and chelating agents.
Bjørklund G; Oliinyk P; Lysiuk R; Rahaman MS; Antonyak H; Lozynska I; Lenchyk L; Peana M
Arch Toxicol; 2020 Jun; 94(6):1879-1897. PubMed ID: 32388818
[TBL] [Abstract][Full Text] [Related]
12. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
Bjørklund G; Mutter J; Aaseth J
Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
[TBL] [Abstract][Full Text] [Related]
13. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
Aposhian HV
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487
[TBL] [Abstract][Full Text] [Related]
14. DMPS can reverse the features of severe mercury vapor-induced neurological damage.
Bradberry SM; Sheehan TM; Barraclough CR; Vale JA
Clin Toxicol (Phila); 2009 Nov; 47(9):894-8. PubMed ID: 19852623
[TBL] [Abstract][Full Text] [Related]
15. Respiratory effect related to exposure of different concentrations of arsenic in drinking water in West Bengal, India.
Chattopadhyay BP; Mukherjee AK; Gangopadhyay PK; Alam J; Roychowdhury A
J Environ Sci Eng; 2010 Apr; 52(2):147-54. PubMed ID: 21114123
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic acid to occupationally exposed men.
Torres-Alanís O; Garza-Ocañas L; Pineyro-Lopez A
J Toxicol Clin Toxicol; 1995; 33(6):717-20. PubMed ID: 8523500
[TBL] [Abstract][Full Text] [Related]
17. Arsenic induced blood and brain oxidative stress and its response to some thiol chelators in rats.
Flora SJ; Bhadauria S; Pant SC; Dhaked RK
Life Sci; 2005 Sep; 77(18):2324-37. PubMed ID: 15964026
[TBL] [Abstract][Full Text] [Related]
18. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning.
Heinrich-Ramm R; Schaller H; Horn J; Angerer J
Arch Toxicol; 2003 Feb; 77(2):63-8. PubMed ID: 12590357
[TBL] [Abstract][Full Text] [Related]
19. Arsenic in the environment: effects on human health and possible prevention.
Singh N; Kumar D; Sahu AP
J Environ Biol; 2007 Apr; 28(2 Suppl):359-65. PubMed ID: 17929751
[TBL] [Abstract][Full Text] [Related]
20. Chronic arsenic toxicity: studies in West Bengal, India.
Guha Mazumder D; Dasgupta UB
Kaohsiung J Med Sci; 2011 Sep; 27(9):360-70. PubMed ID: 21914522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
